Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Halozyme Therapeutics
HALO
5
Precision Drilling
PDS
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.06%2.45B | -5.12%580.37M | -0.40%629.97M | 2.55%621.66M | 3.30%618.48M | 8.57%2.45B | 6.07%611.67M | 9.38%632.48M | 9.72%606.21M | 9.20%598.72M |
Operating revenue | 0.06%2.45B | -5.12%580.37M | -0.40%629.97M | 2.55%621.66M | 3.30%618.48M | 8.57%2.45B | 6.07%611.67M | 9.38%632.48M | 9.72%606.21M | 9.20%598.72M |
Cost of revenue | 1.63%1.12B | -3.25%267.78M | -0.33%286.24M | 5.04%284.88M | 5.28%284.26M | 9.51%1.11B | 11.49%276.78M | 14.55%287.17M | 8.30%271.22M | 3.91%270.01M |
Gross profit | -1.23%1.33B | -6.66%312.59M | -0.45%343.74M | 0.53%336.77M | 1.68%334.23M | 7.82%1.34B | 1.97%334.89M | 5.42%345.31M | 10.90%334.99M | 13.97%328.72M |
Operating expense | 7.87%1.34B | -16.46%294.58M | 19.81%345.14M | 3.06%312.22M | 30.16%384.72M | 15.08%1.24B | 19.88%352.62M | 8.86%288.06M | 17.70%302.95M | 11.16%295.57M |
Selling and administrative expenses | 7.69%957.12M | -0.89%231.36M | 26.96%267.34M | 4.33%233.44M | 1.79%224.97M | 14.50%888.79M | 5.58%233.45M | 10.39%210.58M | 22.53%223.76M | 18.17%221.01M |
-Selling and marketing expense | 7.69%957.12M | -0.89%231.36M | 26.96%267.34M | 4.33%233.44M | 1.79%224.97M | 14.50%888.79M | 5.58%233.45M | 10.39%210.58M | 22.53%223.76M | --221.01M |
Depreciation amortization depletion | 8.31%379.54M | -46.95%63.22M | 0.40%77.8M | -0.51%78.78M | 114.25%159.75M | 16.59%350.41M | 63.13%119.17M | 4.92%77.49M | 5.90%79.19M | -5.48%74.56M |
-Depreciation and amortization | 8.31%379.54M | -46.95%63.22M | 0.40%77.8M | -0.51%78.78M | 114.25%159.75M | 16.59%350.41M | 63.13%119.17M | 4.92%77.49M | 5.90%79.19M | -5.48%74.56M |
Operating profit | -108.92%-9.34M | 201.55%18.01M | -102.45%-1.4M | -23.38%24.55M | -252.31%-50.49M | -38.30%104.7M | -151.74%-17.73M | -9.06%57.24M | -28.26%32.04M | 47.20%33.15M |
Net non-operating interest income expense | -4.35%-289.63M | 10.78%-68.32M | -4.74%-73.98M | -10.59%-74.2M | -15.60%-73.13M | -33.34%-277.56M | -21.41%-76.57M | -31.84%-70.63M | -46.40%-67.09M | -38.48%-63.26M |
Non-operating interest income | 239.70%20.72M | ---- | ---- | ---- | ---- | 890.10%6.1M | ---- | ---- | ---- | ---- |
Non-operating interest expense | 9.41%310.35M | 7.70%89.04M | 4.74%73.98M | 10.59%74.2M | 15.60%73.13M | 35.87%283.66M | 29.82%82.67M | 31.84%70.63M | 46.40%67.09M | 38.48%63.26M |
Other net income (expense) | -1,868.62%-253.54M | 95.09%-16.47M | -4,502.61%-206.11M | 37.42%-12.05M | -105.46%-18.91M | 96.90%-12.88M | 31.37%-335.34M | 41.40%-4.48M | -129.12%-19.25M | 1,677.26%346.19M |
Gain on sale of security | 80.28%-3.69M | 200.46%33.37M | -459.18%-47.18M | 23.33%7.3M | 161.55%2.82M | -156.61%-18.74M | -1,175.99%-33.21M | 4,429.31%13.14M | -72.90%5.92M | ---4.58M |
Earnings from equity interest | -143.48%-1.85M | -43.80%-1.57M | -147.60%-1.07M | -76.36%234K | -73.57%555K | --4.26M | ---1.09M | --2.25M | --990K | --2.1M |
Special income (charges) | -35,829.73%-248.99M | 83.36%-50.3M | -681.02%-156.25M | 27.18%-18.98M | -106.75%-23.47M | 99.85%-693K | 38.16%-302.25M | -115.54%-20.01M | -164.11%-26.06M | --347.63M |
-Less:Restructuring and merger&acquisition | -28.45%57.46M | 63.62%21.52M | -68.75%6.25M | -62.40%6.22M | -23.32%23.47M | 62.30%80.31M | -46.98%13.15M | 115.54%20.01M | 63.61%16.54M | --30.6M |
-Less:Impairment of capital assets | 66.11%248.88M | 68.45%236.12M | --0 | 32.16%12.76M | ---- | -67.71%149.83M | -69.79%140.17M | --0 | --9.65M | ---- |
-Less:Other special charges | 62.89%-85.14M | -257.89%-235.14M | --150M | ---- | ---- | -351.95%-229.44M | --148.93M | ---- | ---135K | ---4.04M |
-Gain on sale of business | ---27.8M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --374.19M |
Other non- operating income (expenses) | -56.45%999K | 66.91%2.02M | -1,253.24%-1.6M | -516.33%-604K | 13.64%1.18M | -83.13%2.29M | -55.64%1.21M | -89.70%139K | -102.72%-98K | -94.66%1.04M |
Income before tax | -197.46%-552.5M | 84.46%-66.79M | -1,475.53%-281.48M | -13.62%-61.7M | -145.09%-142.53M | 59.13%-185.74M | 16.97%-429.65M | -1,132.72%-17.87M | -183.62%-54.3M | 8,675.09%316.08M |
Income tax | 765.61%15.25M | 112.56%19M | -176.54%-33.63M | 94.76%-1.5M | -77.22%31.38M | 106.09%1.76M | -405.59%-151.27M | 3,764.20%43.94M | -627.22%-28.65M | 2,570.71%137.74M |
Net income | -202.80%-567.75M | 69.18%-85.79M | -301.05%-247.86M | -134.67%-60.2M | -197.52%-173.91M | 55.94%-187.5M | 42.90%-278.38M | -10,521.92%-61.8M | -143.11%-25.65M | 9,340.76%178.34M |
Net income continuous Operations | -202.80%-567.75M | 69.18%-85.79M | -301.05%-247.86M | -134.67%-60.2M | -197.52%-173.91M | 55.94%-187.5M | 42.90%-278.38M | -10,521.92%-61.8M | -143.11%-25.65M | 9,340.76%178.34M |
Minority interest income | ||||||||||
Net income attributable to the parent company | -202.80%-567.75M | 69.18%-85.79M | -301.05%-247.86M | -134.67%-60.2M | -197.52%-173.91M | 55.94%-187.5M | 42.90%-278.38M | -10,521.92%-61.8M | -143.11%-25.65M | 9,340.76%178.34M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -202.80%-567.75M | 69.18%-85.79M | -301.05%-247.86M | -134.67%-60.2M | -197.52%-173.91M | 55.94%-187.5M | 42.90%-278.38M | -10,521.92%-61.8M | -143.11%-25.65M | 9,340.76%178.34M |
Basic earnings per share | -233.62%-11.71 | 65.75%-1.75 | -343.48%-5.1 | -158.33%-1.24 | -210.06%-3.61 | 52.05%-3.51 | 42.39%-5.11 | -11,600.00%-1.15 | -148.98%-0.48 | 10,833.33%3.28 |
Diluted earnings per share | -233.62%-11.71 | 65.75%-1.75 | -343.48%-5.1 | -158.33%-1.24 | -211.42%-3.61 | 52.05%-3.51 | 42.39%-5.11 | -11,600.00%-1.15 | -148.98%-0.48 | 10,700.00%3.24 |
Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |